Font: Financial Modeling Prep • Apr 01, 2026
PVH Corp. (NYSE: PVH) reported fourth-quarter results that exceeded analyst expectations, though the company cautioned about significant tariff-related pressures going forward. Shares rose more than 9% intraday Wednesday following the announcement.
The parent company of Calvin Klein and Tommy Hilfiger reported adjusted earnings per share of $3.82, beating the consensus estimate of $3.30. Revenue increased 6% year over year to $2.51 billion, surpassing analyst expectations of $2.43 billion, while remaining flat on a constant currency basis.
For fiscal 2026, PVH projected adjusted EPS in the range of $11.80 to $12.10, with a midpoint of $11.95 exceeding the consensus estimate of $11.88. However, the outlook incorporates an estimated gross negative impact of approximately $3.30 per share from tariffs on U.S. imports, partially offset by mitigation measures.
The company expects full-year 2026 revenue to increase slightly compared to 2025.
For the first quarter of 2026, PVH forecast adjusted EPS between $1.65 and $1.80, down from $2.30 in the prior-year period. It also projected a full-year adjusted operating margin of approximately 8.8%, unchanged from 2025, despite an anticipated 215 basis point headwind from tariffs.
|
GV§>
Visionary Holdings Inc.
|
$0.44
116.78%
|
|
LNKS§>
Linkers Industries Limited
|
$0.01
-35.16%
|
|
AIXI§>
Xiao-I Corporation
|
$0.13
33.10%
|
|
SKYQ§>
Sky Quarry Inc.
|
$5.10
101.58%
|
|
NVDA§>
NVIDIA Corporation
|
$177.39
0.93%
|
|
BITO§>
ProShares - Bitcoin ETF
|
$9.21
-1.60%
|
|
COCP§>
Cocrystal Pharma, Inc.
|
$1.51
48.04%
|
|
TSLL§>
Direxion Daily TSLA Bull 2X ETF
|
$11.37
-10.96%
|
|
SPDN§>
Direxion Daily S&P 500 Bear 1X ETF
|
$9.87
0.10%
|
|
BDRX§>
Biodexa Pharmaceuticals Plc
|
$0.87
42.23%
|